Oscar Health, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Oscar Health, Inc. (OSCR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $44.78 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-02-13
- Oscar Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2021-12-31 was $4.67M.
- Oscar Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2021-09-30 was $9.32M.
- Oscar Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2021-06-30 was $5.15M.
- Oscar Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2021-03-31 was $91.86M.
- Oscar Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $44.78M, a 37.55% decline from fiscal 2024.
- Oscar Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $71.70M, a 743.53% increase from fiscal 2023.
- Oscar Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $8.50M, a 750.00% increase from fiscal 2022.
- Oscar Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $1.00M, a 99.10% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $44.78M 10-K · filed 2026-02-13 | ||||
| 2024-12-31 | $71.70M 10-K · filed 2026-02-13 | $71.69M 10-K · filed 2025-02-20 | |||
| 2023-12-31 | $8.50M 10-K · filed 2026-02-13 | $8.49M 10-K · filed 2024-02-15 | |||
| 2022-12-31 | $1.00M 10-K · filed 2025-02-20 | $999.00K 10-K · filed 2023-02-24 | |||
| 2021-12-31 | $4.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $13.99M derived: sum of 2 quarters · filed 2024-02-15 | $19.14M derived: sum of 3 quarters · filed 2024-02-15 | $111.00M 10-K · filed 2024-02-15 | $111.02M 10-K · filed 2022-02-25 |
| 2021-09-30 | $9.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $14.47M derived: sum of 2 quarters · filed 2021-11-12 | $106.33M 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | $5.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $97.01M 10-Q · filed 2021-08-13 | |||
| 2021-03-31 | $91.86M 10-Q · filed 2021-05-14 | ||||
| 2020-12-31 | $14.20M 10-K · filed 2023-02-24 | ||||
| 2019-12-31 | $3.40M 10-K · filed 2022-02-25 |